News
Oncoinvent ASA: EX. SUBSCRIPTION RIGHTS IN RIGHTS ISSUE TODAY
Oncoinvent ASA: Terms of the underwritten Rights Issue
Oncoinvent ASA: Updated Key Information related to the contemplated Rights Issue
Reminder: Invitation to presentation of Q3 2025 company update on November 4[th], 2025
Mandatory notification of trade
Oncoinvent appoints Dr. Ramzi Amri as new CFO
Merger of BerGenBio and Oncoinvent completed
BerGenBio and Oncoinvent – Last day of trading in the shares of Oncoinvent
BerGenBio ASA: Approval and publication of prospectus
